Guanzhao Liang

Dr. Guanzhao Liang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in Mycoses
Verified
Journal Article
Closed access
PDF file
GLGuanzhao Liang
Guanzhao Liang
XZXiaoli Zheng
Xiaoli Zheng
GSGe Song
Ge Song
MZMeijie Zhang
Meijie Zhang
JLJia Liu
Jia Liu
WLWeida Liu
Weida Liu

19 June 2023 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
XKXue Kong
Xue Kong
GSGe Song
Ge Song
HMHuan Mei
Huan Mei
HZHailin Zheng
Hailin Zheng
CTChao Tang
Chao Tang
GLGuanzhao Liang
Guanzhao Liang

5 January 2024 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
WXWenting Xie
Wenting Xie
XKXue Kong
Xue Kong
HZHailin Zheng
Hailin Zheng
HMHuan Mei
Huan Mei
NGNaicen Ge
Naicen Ge
XLXiaofang Li
Xiaofang Li
We describe 14 cases of native refractory dermatophytes caused by Trichophyton indotineae diagnosed at a hospital in China since 2021, primarily diagnosed in the past 1 year and from the same province. Trichophyton indotineae isolates were resistant to multiple antifungals and harboured Phe397Leu or Leu393Ser substitutions in the squalene epoxidase enzyme. Short-term rapid emergence of multidrug-resistant T. indotineae in China poses increasing threats to public safety and warrants continued public health surveillance.

1 February 2022 in Mycoses
Verified
Journal Article
Closed access
PDF file
GSGe Song
Ge Song
MZMeijie Zhang
Meijie Zhang
WLWeida Liu
Weida Liu
GLGuanzhao Liang
Guanzhao Liang

10 July 2022 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
GSGe Song
Ge Song
MZMeijie Zhang
Meijie Zhang
WLWeida Liu
Weida Liu
GLGuanzhao Liang
Guanzhao Liang

12 May 2025 in Emerging Microbes & Infections
Verified
Journal Article
Open access
WXWenting Xie
Wenting Xie
GLGuanzhao Liang
Guanzhao Liang
XKXue Kong
Xue Kong
Clement K.M. TsuiClement K.M. Tsui
Clement K.M. Tsui
XSXiaodong She
Xiaodong She
XLXiao-Fang Li
Xiao-Fang Li
S:The emergence and spread of antifungal-resistant Trichophyton indotineae pose an increasing public health concern worldwide. Multidrug-resistant T. indotineae infections have been reported in China in the past few years. To understand the genetic relationship and the origin of these Chinese isolates, as well as their relationship to the global collections, we sequenced the whole genomes of 31 isolates using the Illumina platforms. Genomic epidemiology was performed on a dataset of 181 T. indotineae isolates from China and 8 other countries, representing the largest genome-wide analysis. Single nucleotide polymorphism analysis revealed that T. indotineae can be divided into four distinct phylogenetic groups (I, II, III, IV), with regional clonal transmission clusters identified in eastern China; T. indotineae was introduced into China more than once given the genetic variability. The isolates from South Asia may be the source of Chinese isolates based on epidemiological information. There were differences in the prevalence and resistance profiles among four phylogenetic groups, with Group III being predominant and exhibiting a higher terbinafine resistance rate of 88.24% and azole resistance. Also, we characterised the role of gene mutation, copy number variation, and gene expression in antifungal drug resistance. Terbinafine resistance could be mainly associated with Phe397Leu substitution in SQLE, and azole resistance might be related to increased copy number of CYP51B, as well as elevated MDR2 and MDR3 expression. Given the clinical challenges posed by T. indotineae, this emerging dermatophyte should be recognised as a global threat, necessitating urgent collaborative surveillance and management strategies.